Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The query "mRNA of Protein Kinase A regulatory subunit I alpha" refers specifically to the messenger RNA (mRNA) transcript that encodes the **cAMP-dependent protein kinase type I-alpha regulatory subunit** (gene symbol: PRKAR1A). While the mRNA is essential for the expression of the PRKAR1A protein, which functions as the regulatory subunit of type I protein kinase A (PKA), *mRNA itself is not considered a direct therapeutic target* in the same sense as receptors, enzymes, or protein complexes[4][5]. Rather, research and clinical focus relate to the PRKAR1A protein product, not its mRNA—except in the context of genetic tests, gene expression studies, or RNA-targeting therapeutics. If your intention is to retrieve structured information about a therapeutic protein target, the correct target should be the **PRKAR1A protein** (the protein product of the mRNA)[5][7][8].\n\n**Clarification:** \n- The PRKAR1A mRNA is the transcript, not the druggable protein. \n- The appropriate canonical form for a therapeutic target is "cAMP-dependent protein kinase type I-alpha regulatory subunit" or "PRKAR1A" (for the protein), not its mRNA[5][8].\n- Please clarify if you are interested in RNA interference, antisense, or other RNA-targeting modalities that may treat the mRNA as a drug target, which is rare and very specific.\n\n**Summary of Correct Entity for Target Assessment:** \n- The **PRKAR1A gene** encodes the regulatory subunit type I-alpha of protein kinase A, a critical modulator of cAMP signaling, with known roles in endocrine tumor syndromes (e.g., Carney complex) and potentially other diseases[4][5][7]. \n- The **PRKAR1A protein** is a validated molecular target with therapeutic and biomarker relevance. \n- The **mRNA** is not conventionally classified as a therapeutic target except in specialized gene-targeted therapies.\n\n**Recommendation:** \n- Use "cAMP-dependent protein kinase type I-alpha regulatory subunit" (PRKAR1A) as the canonical target for drug discovery, therapeutic, or biomarker purposes[5][8].\n- Use "PRKAR1A mRNA" only for gene expression, RNA biology, or RNA-targeting therapeutic queries.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on cAMP-dependent protein kinase type I-alpha regulatory subunit mRNA (PRKAR1A mRNA).